Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chad K Porter

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
Ebiomedicine|April 16, 2021
Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protectionKawsar R Talaat, Cristina Alaimo, Patricia Martin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2017
Rifaximin Fails to Prevent Campylobacteriosis in the Human Challenge Model: A Randomized, Double-Blind, Placebo-Controlled TrialJoanna E Rimmer, Clayton Harro, David A Sack, et al.
Nature Immunology|July 30, 2024
A unique serum IgG glycosylation signature predicts development of Crohn's disease and is associated with pathogenic antibodies to mannose glycanJoana Gaifem, Cláudia S Rodrigues, Francesca Petralia, et al.
The Lancet. Infectious Diseases|June 30, 2026
Efficacy of WRSs2, a live-attenuated Shigella sonnei vaccine, against shigellosis in a controlled human infection model in the USA: a phase 2, double-blind, randomised, placebo-controlled trialNadine Rouphael, Shahida Baqar, Michelle Dickey, et al.
The Journal of Clinical Investigation|May 18, 2018
Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severityPardeep Kumar, F Matthew Kuhlmann, Subhra Chakraborty, et al.
The Journal of Clinical Investigation|July 2, 2019
Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severityPardeep Kumar, F Matthew Kuhlmann, Subhra Chakraborty, et al.
Plos Pathogens|September 16, 2024
Repeat modules and N-linked glycans define structure and antigenicity of a critical enterotoxigenic E. coli adhesinZachary T Berndsen, Marjahan Akhtar, Mahima Thapa, et al.
Human Vaccines & Immunotherapeutics|November 14, 2024
A randomized clinical trial of the impact of melatonin on influenza vaccine: Outcomes from the melatonin and vaccine response immunity and chronobiology study (MAVRICS)Rachel U Lee, Nora L Watson, Gena L Glickman, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
Repeat modules and N-linked glycans define structure and antigenicity of a critical enterotoxigenic <i>E. coli adhesin</i>Zachary T Berndsen, Marjahan Akhtar, Mahima Thapa, et al.
Nature Microbiology|March 29, 2018
Campylobacter jejuni transcriptional and genetic adaptation during human infectionAlexander A Crofts, Frédéric M Poly, Cheryl P Ewing, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Ebiomedicine|April 16, 2021
Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protectionKawsar R Talaat, Cristina Alaimo, Patricia Martin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2017
Rifaximin Fails to Prevent Campylobacteriosis in the Human Challenge Model: A Randomized, Double-Blind, Placebo-Controlled TrialJoanna E Rimmer, Clayton Harro, David A Sack, et al.
Nature Immunology|July 30, 2024
A unique serum IgG glycosylation signature predicts development of Crohn's disease and is associated with pathogenic antibodies to mannose glycanJoana Gaifem, Cláudia S Rodrigues, Francesca Petralia, et al.
The Lancet. Infectious Diseases|June 30, 2026
Efficacy of WRSs2, a live-attenuated Shigella sonnei vaccine, against shigellosis in a controlled human infection model in the USA: a phase 2, double-blind, randomised, placebo-controlled trialNadine Rouphael, Shahida Baqar, Michelle Dickey, et al.
The Journal of Clinical Investigation|May 18, 2018
Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severityPardeep Kumar, F Matthew Kuhlmann, Subhra Chakraborty, et al.
The Journal of Clinical Investigation|July 2, 2019
Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severityPardeep Kumar, F Matthew Kuhlmann, Subhra Chakraborty, et al.
Plos Pathogens|September 16, 2024
Repeat modules and N-linked glycans define structure and antigenicity of a critical enterotoxigenic E. coli adhesinZachary T Berndsen, Marjahan Akhtar, Mahima Thapa, et al.
Human Vaccines & Immunotherapeutics|November 14, 2024
A randomized clinical trial of the impact of melatonin on influenza vaccine: Outcomes from the melatonin and vaccine response immunity and chronobiology study (MAVRICS)Rachel U Lee, Nora L Watson, Gena L Glickman, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
Repeat modules and N-linked glycans define structure and antigenicity of a critical enterotoxigenic <i>E. coli adhesin</i>Zachary T Berndsen, Marjahan Akhtar, Mahima Thapa, et al.
Nature Microbiology|March 29, 2018
Campylobacter jejuni transcriptional and genetic adaptation during human infectionAlexander A Crofts, Frédéric M Poly, Cheryl P Ewing, et al.
Pageof 13